Mosaicism in Pallister i(12p) syndrome.
The clinical diagnosis of Pallister syndrome in a 1-day-old white boy was confirmed by the presence of i(12p) in 100% of cells on direct bone marrow analysis. This is the second Pallister syndrome case in which cytogenetic diagnosis was made in bone marrow cells during the neonatal period. Other tissues analyzed in our patient included peripheral blood PHA-stimulated cultured lymphocytes and postmortem skin and lung cultured fibroblasts with 3%, 98.5%, and 97.5% of cells containing the i(12p), respectively. Serial skin fibroblast cultures re-established from frozen cells were analyzed sequentially over time for the isochromosome. There was slight reduction in the proportion of i(12p) cells until passage 15 with plateauing of the proportion of i(12p) cells at about 80% until culture senescence. Our review of such cytogenetic analyses suggests that in vivo and perhaps also in vitro isochromosome loss best explains the intra- and inter-tissue specific chromosomal mosaicism in the i(12p) syndrome. In any event, our results indicate that confirmation of the diagnosis in the neonatal period is possible by direct cytogenetic analysis of bone marrow.
Wenger
S L
SL
Division of Medical Genetics, Children's Hospital of Pittsburgh, Pennsylvania 15213-2583.
Boone
L Y
LY
Steele
M W
MW
D001854:Bone Marrow Cells; D001856:Bone Marrow Examination; D002869:Chromosome Aberrations / Q000175:diagnosis*; D025063:Chromosome Disorders; D002881:Chromosomes, Human, Pair 12; D005147:Facial Bones / Q000002:abnormalities*; D006801:Humans; D006972:Hypertelorism / Q000175:diagnosis; D007021:Hypospadias / Q000175:diagnosis; D007231:Infant, Newborn; D008297:Male; D009030:Mosaicism / Q000235:genetics*; D013577:Syndrome